Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v7-EN
Language English English
Date Updated 2017-12-12 2017-12-11
Drug Identification Number 00885975 00885975
Brand name VIVOTIF VIVOTIF
Common or Proper name Typhoid vaccine live oral attenuated Ty21a vaccine Typhoid vaccine live oral attenuated Ty21a vaccine
Company Name BAVARIAN NORDIC AS BAVARIAN NORDIC AS
Ingredients TYPHOID VACCINE TYPHOID VACCINE
Strength(s) 10B 10B
Dosage form(s) CAPSULE (ENTERIC-COATED) CAPSULE (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size Single foil blister with 4 enteric-coated capsules Single foil blister with 4 enteric-coated capsules
ATC code J07AP J07AP
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-11-17 2017-11-17
Estimated end date 2017-12-22 2017-12-22
Actual end date 2017-12-11 2017-12-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Supply released on 11. December 2017 Supply released on 11. December 2017
Health Canada comments